Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.

Journal of lipid research - 1 Jun 1997

Ribalta J, La Ville A E, Vallvé J C, Humphries S, Turner P R, Masana L

Abstract excerpt

Detailed plasma lipoprotein analyses were conducted on 16 familial combined hyperlipidemic (FCHL) probands, all their available family members (n = 106) together with 12 normolipidemic control families (n = 68), and the results were assessed in relation to a C1100-T polymorphism in exon 3 of the apoC-III gene. The frequency of the T1100 genotype (CT+TT) was significantly elevated in the probands relative to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Alleles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Base Sequence

Share to Cholesterol

Share to DNA Primers

Share to Gene Frequency

Share to Genotype

Share to Lipoproteins

Source

Identifiers

PMID: 9215535

Genes

LPL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.PMID 9215535Read ↗

New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia.Semantic proximity Read ↗

Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia.Semantic proximity Read ↗

ANGPTL3 gene variants in subjects with familial combined hyperlipidemia.Semantic proximity Read ↗

Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization.Semantic proximity Read ↗

Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.Semantic proximity Read ↗

Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.Semantic proximity Read ↗

The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.Semantic proximity Read ↗

Recent developments in the genetics of LDL deficiency.Semantic proximity Read ↗

Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis.Semantic proximity Read ↗

ANGPTL3 serum concentration and rare genetic variants in Finnish population.Semantic proximity Read ↗

Novel genes for familial combined hyperlipidemia.Semantic proximity Read ↗

Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.